Association between anthropometric clinical predictors and HOMA-IR
Main Article Content
Keywords
Insulin Resistance, HOMA-IR, Waist-to-Hip Ratio, Body Mass Index
Abstract
Abstract
Background: The HOMA-IR index is a test that identifies the early risk of developing type 2 diabetes mellitus (T2DM) by measuring insulin resistance (IR); however, these tests are not readily available in primary care settings. Predictors of IR, such as body mass index (BMI) and waist-to-hip ratio (WHR), are useful for the early detection of this risk.
Objective: To associate anthropometric parameters with HOMA-IR, considering BMI.
Material and methods: A cross-sectional, comparative study was conducted. Serum glucose and insulin concentrations were determined using non-probability convenience sampling and the difference of proportions formula to calculate the HOMA-IR index in 315 adults without diabetes. Anthropometric parameters and visceral fat were considered, and participants were divided into groups according to BMI: normal weight, overweight, and obesity. Differences between groups were determined by Kruskal-Wallis test and the risk of each variable through multiple logistic regression.
Results: Of the 315 participants, 57% showed IR; most of them belonged to the overweight and obesity group. Serum insulin concentrations and IR differed significantly among the 3 BMI groups, primarily in the overweight and obesity groups. WHR is a good predictor of risk for IR.
Conclusions: IR can be early detected by using validated indices such as HOMA-IR. At the primary care level, anthropometric parameters such as WHR can be used, as it has proven to be a better predictor of IR, phenomenon that occurs much earlier than hyperglycemia.
References
1. Lu X, Xie Q, Pan X, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Sig Transduct Target Ther. el 2 de octubre de 2024;9(1):262. doi: 10.1038/s41392-024-01951-9
2. Freeman AM, Acevedo LA, Pennings N. Insulin Resistance. StatPearls; 2023. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK507839/
3. Janssen JAMJL. Hyperinsulinemia and Its Pivotal Role in Aging, Obesity, Type 2 Diabetes, Cardiovascular Disease and Cancer. Int J Mol Sci. 2021;22(15):7797. doi: 10.3390/ijms22157797
4. Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich). 2021;23(3):529-37. doi: 10.1111/jch.14155
5. Tahapary DL, Pratisthita LB, Fitri NA, et al. Challenges in the diagnosis of insulin resistance: Focusing on the role of HOMA-IR and Tryglyceride/glucose index. Diabetes Metab Syndr. 2022;16(8):102581. doi: 10.1016/j.dsx.2022.102581
6. Lozano DL, Camarillo-Nava VM, Juárez-Zepeda TE, et al. Costo-efectividad del tratamiento de la diabetes mellitus tipo 2 en México. Rev Med Inst Mex Seguro Soc. 2023;61(2):172-80. Disponible en: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/4743/4544
7. Schmidt MI, Bracco PA, Yudkin JS, et al. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil. Lancet Diabetes Endocrinol. 2019;7(4):267-277. doi: 10.1016/S2213-8587(19)30058-0
8. González-González JG, Violante-Cumpa JR, Zambrano-Lucio M, et al. HOMA-IR as a predictor of health outcomes in patients with metabolic risk factors: A systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2022;29(6):547-64. doi: 10.1007/s40292-022-00542-5
9. Tabák AG, Jokela M, Akbaraly TN, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-21. doi: 10.1016/S0140-6736(09)60619-X
10. Echouffo-Tcheugui JB, Perreault L, Ji L, et al. Diagnosis and Management of Prediabetes: A Review. JAMA. 2023;329(14):1206. doi: 10.1001/jama.2023.4063
11. Acosta AM, Escalona M, Maiz A, et al. Determinación del índice de resistencia insulínica mediante HOMA en una población de la Región Metropolitana de Chile. Rev Méd Chile. 2002;130(11). doi: 10.4067/S0034-98872002001100004
12. Widjaja NA, Arifani R, Irawan R. Valor de la relación cintura-cadera como predictor del síndrome metabólico en adolescentes con obesidad. Acta Biomed. 2023;94(3). doi: 10.23750/abm.v94i3.13755
13. Barquera S, Hernández-Barrera L, Oviedo-Solís C, et al. Obesidad en adultos. Salud Publica Mex. 2024;66(4):414-24. doi: 10.21149/15863
14. Vizzuso S, Del Torto A, Dilillo D, et al. Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS). Nutrients. el 28 de enero de 2021;13(2):413. doi: 10.3390/nu13020413
15. Valverde Pulla J, Prieto Fuentemayor C. Índice HOMA-IR como indicador de riesgo de enfermedades endocrino-metabólicas en niños y adolescentes con obesidad. Revista Vive. 2021;4(11):173-92. doi: 10.33996/revistavive.v4i11.86
16. Xu H, Jin C, Guan Q. Causal Effects of Overall and Abdominal Obesity on Insulin Resistance and the Risk of Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization Study. Front Genet. 2020;11:603. doi: 10.3389/fgene.2020.00603
17. Malandrino N, Metter EJ, Simonsick EM, et al. Body Mass Index and Diabetes Incidence Across the Adult Lifespan: The Baltimore Longitudinal Study of Aging. Journal of the Endocrine Society. 2024;8(11):bvae156. doi: 10.1210/jendso/bvae156
18. Bellou V, Belbasis L, Tzoulaki I, et al. Risk factors for type 2 diabetes mellitus: An exposure-wide umbrella review of meta-analyses. PLoS ONE. 2018;13(3):e0194127. doi: 10.1371/journal.pone.0194127
19. Tatti P, Singh P. Insulin Resistance: An Unresolved Riddle. J Clin Med. 2023;12(19):6394. doi: 10.3390/jcm12196394
20. Warram JH, Martin BC, Krolewski AS, et al. Slow Glucose Removal Rate and Hyperinsulinemia Precede the Development of Type II Diabetes in the Offspring of Diabetic Parents. Ann Intern Med. 1990;113(12):909-15. doi: 10.7326/0003-4819-113-12-909
21. Jayedi A, Soltani S, Motlagh SZ, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2022;376:e067516. doi: 10.1136/bmj-2021-067516
22. Wu J, Guo J. Is weight-adjusted waist index more strongly associated with diabetes than body mass index and waist circumference?: Results from the database large community sample study. PLoS ONE. 2024;19(9):e0309150. doi: 10.1371/journal.pone.0309150
23. Zhu M, Wang K, Feng J, et al. The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome. Front Endocrinol. 2024;15:1502321. doi: 10.3389/fendo.2024.1502321
24. Almeda-Valdés P, Bello-Chavolla OY, Caballeros-Barragán CR, et al. Índices para la evaluación de la resistencia a la insulina en individuos mexicanos sin diabetes. Gac Med Mex. 2018;154(92):1240. doi: 10.24875/GMM.18004578
25. Nikbakht R, Zargar M, Moramezi F, et al. Insulin Resistance and Free Androgen as Predictors for Ovarian Hyperstimulation Syndrome in Non-PCOS Women. Horm Metab Res. febrero de 2020;52(02):104-8. doi: 10.1055/a-1079-5342
26. Barbosa-Cortes L, Villasis-Keever MA, Del Prado-Manriquez M, et al. Adiposity and Insulin Resistance in Children from a Rural Community in Mexico. Archives of Medical Research. 2015;46(3):214-20. doi: 10.1016/j.arcmed.2015.03.010
27. Santos Lozano E. Resistencia a Insulina: Revisión de literatura. Rev Méd Hondur. 2022;90(1):63-70. doi: 10.5377/rmh.v90i1.13824
28. Vega-Cárdenas M, Flores-Sánchez J, Torres-Rodriguez ML, et al. Distribution of TyG index and homeostasis model assessment insulin resistance for the evaluation of insulin sensitivity on late adolescence in Mexicans. Nutr Hosp. 2022; doi: 10.20960/nh.04120
29. Abdul-Ghani M, DeFronzo RA. Fasting Hyperinsulinemia and Obesity: Cause or Effect. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e1151-2. doi: 10.1210/clinem/dgad118
30. Mehta M, Shah J, Joshi U. Understanding Insulin Resistance in NAFLD: A systematic review and meta-analysis focused on HOMA-IR in south Asians. Cureus. 2024;16(10):e70768. doi: 10.7759/cureus.70768
31. Chávez I. Obras Completas. México: El Colegio Nacional; 1959.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.